Author

A. S. Sadr

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Allo Anido· 1 shared A. Bruna· 1 shared A. Shea· 1 shared B. Geoerger· 1 shared B. T. Freitas· 1 shared C. English· 1 shared C. Roux· 1 shared D. J. Najafi· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Allo Anido

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Environment-Dependent Modes of Adaptive Evolution in Neuroblastoma: Plasticity as a Selectable Trait

C. Roux, S. Hamer, A. Shea, E. Chen, A. S. Sadr, C. English, A. Allo Anido, H. Che, B. Geoerger, L. Chesler, G. Schleiermacher, M. D. Morgan, A. Bruna

This study identifies three modes of plasticity in neuroblastoma that shape tumour evolution under selective pressures and therapy resistance.

bioRxiv · Dec 7, 2023 · PreprintCancer Biology

Losartan promotes cell survival following SARS-CoV-2 infection in vitro

R. Nejat, A. S. Sadr, B. T. Freitas, J. Crabtree, S. D. Pegan, R. A. Tripp, D. J. Najafi

This study shows that Losartan reduces SARS-CoV-2 replication in Vero E6 cells by 80% pre-infection and 70% post-infection, promoting cell survival with low side-effects.

bioRxiv · Dec 27, 2020 · PreprintPharmacology & Toxicology